Carol A. Salvadore
Plus aucun poste en cours
Profil
Carol A.
Salvadore worked as a Director at Rich Pharmaceuticals, Inc. from 2017 to 2019.
Prior to that, she worked as a Principal at Cogent Resources Ltd.
She holds a doctorate degree from Rutgers State University of New Jersey and an undergraduate degree from New York University.
Anciens postes connus de Carol A. Salvadore
| Sociétés | Poste | Fin |
|---|---|---|
| RICH PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 24/06/2019 |
Cogent Resources Ltd.
 Cogent Resources Ltd. Insurance Brokers/ServicesFinance Cogent Resources Ltd. provides insurance services. The British company was founded in 1983 by Antony Andrew Barrow. Mark John Alexander Bishop has been the CEO of the private company since 1985. | Corporate Officer/Principal | - |
Formation de Carol A. Salvadore
| Rutgers State University of New Jersey | Doctorate Degree |
| New York University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Rich Pharmaceuticals, Inc.
 Rich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA. | Health Technology |
Cogent Resources Ltd.
Cogent Resources Ltd. Insurance Brokers/ServicesFinance Cogent Resources Ltd. provides insurance services. The British company was founded in 1983 by Antony Andrew Barrow. Mark John Alexander Bishop has been the CEO of the private company since 1985. | Finance |
